Molecular testing, first-line treatment patterns, and survival in metastatic Colombian non-small cell lung cancer: the RECAPC multicenter registry
{{output}}
Background: Molecular profiling and programmed death-ligand 1 (PD-L1) status guide first-line treatment selection in metastatic non-small cell lung cancer, yet real-world testing, treatment delivery, and documentation vary across... ...
